Cargando…
Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO group
Viscosupplementation (VS) is a symptomatic treatment for knee and other joint osteoarthritis (OA). Despite a long history of use, conflicting opinions remain on the best clinical indications and the most appropriate patients to be treated with intra-articular hyaluronic acid (IA-HA), the optimal dos...
Autores principales: | Conrozier, Thierry, Raman, Raghu, Chevalier, Xavier, Henrotin, Yves, Monfort, Jordi, Diraçoglù, Demirhan, Bard, Hervé, Baron, Dominique, Jerosch, Jörg, Richette, Pascal, Migliore, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165874/ https://www.ncbi.nlm.nih.gov/pubmed/34104232 http://dx.doi.org/10.1177/1759720X211018605 |
Ejemplares similares
-
EUROVISCO Good Practice Recommendations for a First Viscosupplementation in Patients with Knee Osteoarthritis
por: Conrozier, Thierry, et al.
Publicado: (2022) -
The role of viscosupplementation in patellar chondropathy
por: da Costa, Sergio Ricardo, et al.
Publicado: (2021) -
Mesenchymal stromal cell products for intra-articular knee injections for conservative management of osteoarthritis
por: Andia, Isabel, et al.
Publicado: (2021) -
Comparison of three treatment protocols with intra-articular low or intermediate molecular weight hyaluronic acid in early symptomatic knee osteoarthritis
por: Galluccio, Felice, et al.
Publicado: (2021) -
Moving toward targeting the right phenotype with the right platelet-rich plasma (PRP) formulation for knee osteoarthritis
por: Andia, Isabel, et al.
Publicado: (2021)